Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.
High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci.
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
Mechanistic insights into the link between inflammation and cardiovascular disease: rheumatoid arthritis as a human model of inflammation.
Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases.
Improving the power of genetic association tests with imperfect phenotype derived from electronic medical records.
